MARKET COMPOSITE
LGND - Ligand Pharmaceuticals, Inc.7:00:43 PM 3/28/2024
Price
$73.11
+ 1.84 (2.58%)
Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenx Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further. Since 2005, the company has twice restated its financial accounts, and it has been subject to class action lawsuits. Fortune ranked Ligand as among the top 100 fastest growing companies for 2014-2016, and in 2018 its CEO was listed among the top five highest paid CEOs in San Diego.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue28.1MM-15%
Operating Income-3.4MM-209%
Operating Expenses31.5MM-
Net Income18.2MM-277%
R&D5.5MM-1%
G&A16MM+9%
Interest Expense131K-
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news